Drug reference

romidepsin

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1178

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(roe-mi-dep′sin) Istodax

PDF page 1178

Functional class

Func. class.: Antineoplastics

PDF page 1178

Uses

USES: Treatment of cutaneous T-cell lymphoma (CTC)L or treatment of peripheral T-cell lymphoma (PTCL) in those who have received at least one prior therapy

PDF page 1178

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity

PDF page 1178

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adult: IV 14 mg/m2 on days 1, 8, and 15 of a 28-day cycle; repeat cycle as long as beneficial

PDF page 1178

Available forms

Available forms: Powder for injection 10-mg vials; solution for injection 27.5 mg/5.5 mL

PDF page 1178

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

romidepsin

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1178

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(roe-mi-dep′sin) Istodax

PDF page 1178

Functional class

Func. class.: Antineoplastics

PDF page 1178

Uses

USES: Treatment of cutaneous T-cell lymphoma (CTC)L or treatment of peripheral T-cell lymphoma (PTCL) in those who have received at least one prior therapy

PDF page 1178

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity

PDF page 1178

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adult: IV 14 mg/m2 on days 1, 8, and 15 of a 28-day cycle; repeat cycle as long as beneficial

PDF page 1178

Available forms

Available forms: Powder for injection 10-mg vials; solution for injection 27.5 mg/5.5 mL

PDF page 1178

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.